IRAK2 directs stimulus-dependent nuclear export of inflammatory mRNAs

  1. Hao Zhou
  2. Katarzyna Bulek
  3. Xiao Li
  4. Tomasz Herjan
  5. Minjia Yu
  6. Wen Qian
  7. Han Wang
  8. Gao Zhou
  9. Xing Chen
  10. Hui Yang
  11. Lingzi Hong
  12. Junjie Zhao
  13. Luke Qin
  14. Koichi Fukuda
  15. Annette Flotho
  16. Ji Gao
  17. Ashok Dongre
  18. Julie A Carman
  19. Zizhen Kang
  20. Bing Su
  21. Timothy S Kern
  22. Jonathan D Smith
  23. Thomas A Hamilton
  24. Frauke Melchior
  25. Paul L Fox
  26. Xiaoxia Li  Is a corresponding author
  1. Cleveland Clinic, United States
  2. Stanford University School of Medicine, United States
  3. Zentrum für Molekulare Biologie der Universität Heidelberg, Germany
  4. Bristol-Myers Squibb, United States
  5. Shanghai Jiao Tong University School of Medicine, China
  6. Case Western Reserve University, United States

Abstract

Expression of inflammatory genes is determined in part by post-transcriptional regulation of mRNA metabolism but how stimulus- and transcript-dependent nuclear export influence is poorly understood. Here we report a novel pathway in which LPS/TLR4 engagement promotes nuclear localization of IRAK2 to facilitate nuclear export of a specific subset of inflammation related mRNAs for translation in murine macrophages. IRAK2 kinase activity is required for LPS-induced RanBP2-mediated IRAK2 sumoylation and subsequent nuclear translocation. Array analysis showed that an SRSF1 binding motif is enriched in mRNAs dependent on IRAK2 for nuclear export. Nuclear IRAK2 phosphorylates SRSF1 to reduce its binding to target mRNAs, which promotes the RNA binding of the nuclear export adaptor ALYREF and nuclear export receptor Nxf1 loading for the export of the mRNAs. In summary, LPS activates a nuclear function of IRAK2 that facilitates the assembly of nuclear export machinery to export selected inflammatory mRNAs to the cytoplasm for translation.

Article and author information

Author details

  1. Hao Zhou

    Department of Immunology, Lerner Research Institute, Cleveland Clinic, Cleveland, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Katarzyna Bulek

    Department of Immunology, Lerner Research Institute, Cleveland Clinic, Cleveland, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Xiao Li

    Department of Genetics, Stanford University School of Medicine, Stanford, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Tomasz Herjan

    Department of Immunology, Lerner Research Institute, Cleveland Clinic, Cleveland, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Minjia Yu

    Department of Immunology, Lerner Research Institute, Cleveland Clinic, Cleveland, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Wen Qian

    Department of Immunology, Lerner Research Institute, Cleveland Clinic, Cleveland, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Han Wang

    Department of Immunology, Lerner Research Institute, Cleveland Clinic, Cleveland, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Gao Zhou

    Department of Genetics, Stanford University School of Medicine, Stanford, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Xing Chen

    Department of Immunology, Lerner Research Institute, Cleveland Clinic, Cleveland, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Hui Yang

    Department of Immunology, Lerner Research Institute, Cleveland Clinic, Cleveland, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Lingzi Hong

    Department of Immunology, Lerner Research Institute, Cleveland Clinic, Cleveland, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Junjie Zhao

    Department of Immunology, Lerner Research Institute, Cleveland Clinic, Cleveland, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. Luke Qin

    Department of Immunology, Lerner Research Institute, Cleveland Clinic, Cleveland, United States
    Competing interests
    The authors declare that no competing interests exist.
  14. Koichi Fukuda

    Department of Molecular Cardiology, Lerner Research Institute, Cleveland Clinic, Cleveland, United States
    Competing interests
    The authors declare that no competing interests exist.
  15. Annette Flotho

    Zentrum für Molekulare Biologie der Universität Heidelberg, Heidelberg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  16. Ji Gao

    Discovery Biology, Bristol-Myers Squibb, Princeton, United States
    Competing interests
    The authors declare that no competing interests exist.
  17. Ashok Dongre

    Discovery Biology, Bristol-Myers Squibb, Princeton, United States
    Competing interests
    The authors declare that no competing interests exist.
  18. Julie A Carman

    Discovery Biology, Bristol-Myers Squibb, Princeton, United States
    Competing interests
    The authors declare that no competing interests exist.
  19. Zizhen Kang

    Department of Immunology, Lerner Research Institute, Cleveland Clinic, Cleveland, United States
    Competing interests
    The authors declare that no competing interests exist.
  20. Bing Su

    Shanghai Institute of Immunology, Shanghai Jiao Tong University School of Medicine, Shanghai, China
    Competing interests
    The authors declare that no competing interests exist.
  21. Timothy S Kern

    School of Medicine, Case Western Reserve University, Cleveland, United States
    Competing interests
    The authors declare that no competing interests exist.
  22. Jonathan D Smith

    Department of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, United States
    Competing interests
    The authors declare that no competing interests exist.
  23. Thomas A Hamilton

    Department of Immunology, Lerner Research Institute, Cleveland Clinic, Cleveland, United States
    Competing interests
    The authors declare that no competing interests exist.
  24. Frauke Melchior

    Zentrum für Molekulare Biologie der Universität Heidelberg, Heidelberg, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9546-8797
  25. Paul L Fox

    Department of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, United States
    Competing interests
    The authors declare that no competing interests exist.
  26. Xiaoxia Li

    Department of Immunology, Lerner Research Institute, Cleveland Clinic, Cleveland, United States
    For correspondence
    lix@ccf.org
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4872-9525

Funding

National Multiple Sclerosis Society (RG5130A2/1)

  • Xiaoxia Li

National Institutes of Health (2PO1HL029582)

  • Xiaoxia Li

American Diabetes Association (Postdoctoral Research Fellow Award,1-16-PDF-138)

  • Hao Zhou

National Science Centre, Poland (2015/19/B/NZ6/01578)

  • Katarzyna Bulek

National Institutes of Health (PO1CA062220)

  • Xiaoxia Li

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All procedures using animals were approved by the Cleveland Clinic Institutional Animal Care and Use Committee (Protocol Number: 2014-1229 and 2017-1814) .

Copyright

© 2017, Zhou et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,650
    views
  • 502
    downloads
  • 28
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Hao Zhou
  2. Katarzyna Bulek
  3. Xiao Li
  4. Tomasz Herjan
  5. Minjia Yu
  6. Wen Qian
  7. Han Wang
  8. Gao Zhou
  9. Xing Chen
  10. Hui Yang
  11. Lingzi Hong
  12. Junjie Zhao
  13. Luke Qin
  14. Koichi Fukuda
  15. Annette Flotho
  16. Ji Gao
  17. Ashok Dongre
  18. Julie A Carman
  19. Zizhen Kang
  20. Bing Su
  21. Timothy S Kern
  22. Jonathan D Smith
  23. Thomas A Hamilton
  24. Frauke Melchior
  25. Paul L Fox
  26. Xiaoxia Li
(2017)
IRAK2 directs stimulus-dependent nuclear export of inflammatory mRNAs
eLife 6:e29630.
https://doi.org/10.7554/eLife.29630

Share this article

https://doi.org/10.7554/eLife.29630

Further reading

    1. Cell Biology
    2. Computational and Systems Biology
    Sarah De Beuckeleer, Tim Van De Looverbosch ... Winnok H De Vos
    Research Article

    Induced pluripotent stem cell (iPSC) technology is revolutionizing cell biology. However, the variability between individual iPSC lines and the lack of efficient technology to comprehensively characterize iPSC-derived cell types hinder its adoption in routine preclinical screening settings. To facilitate the validation of iPSC-derived cell culture composition, we have implemented an imaging assay based on cell painting and convolutional neural networks to recognize cell types in dense and mixed cultures with high fidelity. We have benchmarked our approach using pure and mixed cultures of neuroblastoma and astrocytoma cell lines and attained a classification accuracy above 96%. Through iterative data erosion, we found that inputs containing the nuclear region of interest and its close environment, allow achieving equally high classification accuracy as inputs containing the whole cell for semi-confluent cultures and preserved prediction accuracy even in very dense cultures. We then applied this regionally restricted cell profiling approach to evaluate the differentiation status of iPSC-derived neural cultures, by determining the ratio of postmitotic neurons and neural progenitors. We found that the cell-based prediction significantly outperformed an approach in which the population-level time in culture was used as a classification criterion (96% vs 86%, respectively). In mixed iPSC-derived neuronal cultures, microglia could be unequivocally discriminated from neurons, regardless of their reactivity state, and a tiered strategy allowed for further distinguishing activated from non-activated cell states, albeit with lower accuracy. Thus, morphological single-cell profiling provides a means to quantify cell composition in complex mixed neural cultures and holds promise for use in the quality control of iPSC-derived cell culture models.

    1. Cell Biology
    Joan Chang, Adam Pickard ... Karl E Kadler
    Research Article

    Collagen-I fibrillogenesis is crucial to health and development, where dysregulation is a hallmark of fibroproliferative diseases. Here, we show that collagen-I fibril assembly required a functional endocytic system that recycles collagen-I to assemble new fibrils. Endogenous collagen production was not required for fibrillogenesis if exogenous collagen was available, but the circadian-regulated vacuolar protein sorting (VPS) 33b and collagen-binding integrin α11 subunit were crucial to fibrillogenesis. Cells lacking VPS33B secrete soluble collagen-I protomers but were deficient in fibril formation, thus secretion and assembly are separately controlled. Overexpression of VPS33B led to loss of fibril rhythmicity and overabundance of fibrils, which was mediated through integrin α11β1. Endocytic recycling of collagen-I was enhanced in human fibroblasts isolated from idiopathic pulmonary fibrosis, where VPS33B and integrin α11 subunit were overexpressed at the fibrogenic front; this correlation between VPS33B, integrin α11 subunit, and abnormal collagen deposition was also observed in samples from patients with chronic skin wounds. In conclusion, our study showed that circadian-regulated endocytic recycling is central to homeostatic assembly of collagen fibrils and is disrupted in diseases.